Ex parte KRUANGAM - Page 5




          Appeal No. 1999-1891                                                        
          Application No. 08/421,089                                                  

          relative persuasiveness of the arguments.  See In re Oetiker,               
          977 F.2d 1443, 1445, 24 USPQ2d 1443, 1444 (Fed. Cir. 1992); In              
          re Hedges, 783 F.2d 1038, 1039, 228 USPQ 685, 686 (Fed. Cir.                
          1986); In re Piasecki, 745 F.2d 1468, 1472, 223 USPQ 785, 788               
          (Fed. Cir. 1984); and In re Rinehart, 531 F.2d 1048, 1052, 189              
          USPQ 143, 147 (CCPA 1976).                                                  
               We are further guided by the precedent of our reviewing                
          court that the limitations from the disclosure are not to be                
          imported into the claims.  In re Lundberg, 244 F.2d 543, 548,               
          113 USPQ 530, 534 (CCPA 1957); In re Queener, 796 F.2d 461,                 
          463-64, 230 USPQ 438, 440 (Fed. Cir. 1986).  We also note that              
          the arguments not made separately for any individual claim or               
          claims are considered waived.  See 37 CFR § 1.192 (a) and (c).              
          In re Baxter Travenol Labs., 952 F.2d 388, 391, 21 USPQ2d                   
          1281, 1285 (Fed. Cir. 1991) (“It is not the function of this                
          court to examine the claims in greater detail than argued by                
          an appellant, looking for nonobvious distinctions over the                  
          prior art.”); In re Wiechert, 370 F.2d 927, 936, 152 USPQ 247,              
          254 (CCPA 1967) (“This court has uniformly followed the sound               
          rule that an issue raised below which is not argued in that                 
          court, even if it has been properly brought here by a reason                

                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007